Aurobindo Pharma shares gain after drug maker wins US regulator approval for nasal spray
Aurobindo Pharma share price: Aurobindo Pharma shares gained over two per cent to Rs 1,013.6 apiece on NSE, rising for the fifth session in a row, after the Hyderabad-headquartered drug maker received approval from the US FDA for its nasal spray. Aurobindo Pharma said the product would be launched in the first quarter of the fiscal year 2025.
Aurobindo Pharma: Aurobindo Pharma is an integrated global pharmaceutical company headquartered in Hyderabad. | Representational image | Image source: aurobindo.com